<p>Dr Jamie Chaft and Dr John Heymach discuss the optimal integration of targeted therapy and immunotherapy into the care of patients with localized non-small cell lung cancer.</p>

Dr Jamie Chaft and Dr John Heymach discuss the optimal integration of targeted therapy and immunotherapy into the care of patients with localized non-small cell lung cancer.

Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

Share Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer

Sign up to save your podcasts

Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer

Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer

More shows like Lung Cancer Update

NEJM This Week

Journal of Clinical Oncology (JCO) Podcast

Breast Cancer Update

Hematologic Oncology Update

Prostate Cancer Update

Gastrointestinal Cancer Update

Gynecologic Oncology Update

Dermatologic Oncology Update

Lung Cancer CancerCare Connect Education Workshops

Research To Practice | Oncology Videos

ASCO Daily News

The Long Run with Luke Timmerman

ASCO Guidelines

Lung Cancer Considered

Oncology Today with Dr Neil Love

Business Of Biotech

Two Onc Docs